Clostridium Difficile Infection in Patients with Acute Myelogenous Leukemia and in Patients Undergoing Allogeneic Stem Cell Transplantation: Epidemiology and Risk Factor Analysis-Reference-Cited by-同舟云学术

Clostridium Difficile Infection in Patients with Acute Myelogenous Leukemia and in Patients Undergoing Allogeneic Stem Cell Transplantation: Epidemiology and Risk Factor Analysis

Published:2014-06 Issue:6 Volume:20 Page:823-828
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Vehreschild Maria J.G.T.,Weitershagen David,Biehl Lena M.,Tacke Daniela,Waldschmidt Dirk,Töx Ulrich,Wisplinghoff Hilmar,Bergwelt-Baildon Michael v.,Cornely Oliver A.,Vehreschild Joerg J.

Funder

Gilead

Astellas Pharma

German Federal Ministry of Research and Education

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference27 articles.

1. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Treatment guidance document for Clostridium difficile infection (CDI);Bauer;Clin Microbiol Infect,2009

2. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society For Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA);Cohen;Infect Control Hosp Epidemiol,2010

3. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis;Slimings;J Antimicrob Chemother,2014